Mutation spectrum of fork-head transcriptional factor gene (FOXL2) in Indian Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) patients

British Journal of Ophthalmology

Volumn 95, Issue 6, 2011, Pages 881-886

  Kaur, Inderjeet ^a   Hussain, Avid ^a   Naik, Milind N ^b   Murthy, Ramesh ^b   Honavar, Santosh G ^b  

^a Hyderabad Eye Research Foundation   (India)

^b L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GLYCINE; THREONINE;

5' UNTRANSLATED REGION; ARTICLE; BLEPHAROPHIMOSIS; BLEPHAROPHIMOSIS PTOSIS EPICANTHUS INVERSUS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; FORKHEAD TRANSCRIPTIONAL FACTOR GENE; FRAMESHIFT MUTATION; GENE; GENE DELETION; GENE DOSAGE; GENE DUPLICATION; GENE MUTATION; GENETIC LINKAGE; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INDIAN; MALE; MISSENSE MUTATION; MUTATIONAL ANALYSIS; OVARY POLYCYSTIC DISEASE; PEDIGREE ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLEPHAROPHIMOSIS; CHILD; COHORT STUDIES; DNA MUTATIONAL ANALYSIS; EYELIDS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE DELETION; GENETIC ASSOCIATION STUDIES; HUMANS; INDIA; MALE; MIDDLE AGED; MUTATION, MISSENSE; PEDIGREE; SYNDROME; YOUNG ADULT;

EID: 79956353941     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.177972     Document Type: Article

References (31)

1. Oley C, Baraister M. Blepharophimosis, ptosis, epicanthus inversus syndrome (BPES syndrome). J Med Genet 1988;25:47-51. (Pubitemid 18042303)
2. Nallathambi J, Moumne L, De Baere E, et al. A novel polyalanine expansion in FOXL2: the first evidence for a recessive form of the blepharophimosis syndrome (BPES) associated with ovarian dysfunction. Hum Genet 2007;121:107-12. (Pubitemid 46421147)
3. Crisponi L, Deiana M, Loi A, et al. The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 2001;27:159-66. (Pubitemid 32157442)
4. Cocquet J, De Baere E, Gareil M, et al. Structure, evolution and expression of the FOXL2 transcription unit. Cytogenet Genome Res 2003;101:201-11.
5. Ellsworth BS, Egashira N, Haller JL, et al. FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 2006;20:2796-805. (Pubitemid 44833536)
6. Shah SP, Köbel M, Senz J, et al. Mutation of FOXL2 in granulosa-cell tumors of the ovary. N Engl J Med 2009;360:2719-29. Epub 2009 Jun 10.
7. Uhlenhaut NH, Jakob S, Anlag K, et al. Somatic sex reprogramming of adult ovaries to testes by FOXL2 ablation. Cell 2009;139:1130-42.
8. Batista F, Vaiman D, Dausset J, et al. Potential targets of FOXL2 a transcription factor involved in cranofacial and follicular development, identified by transcriptomics. Proc Natl Acad Sci U S A 2007;104:3330-5. (Pubitemid 46364159)
9. Beysen D, De Paepe A, De Baere E. FOXL2 mutations and genomic rearrangements in BPES. Hum Mutat 2008;30:158-69.
10. Bell R, Murday VA, Patton MA, et al. Two families with blepharophimosis/ptosis/epicanthus inversus syndrome have mutations in the putative forkhead transcription factor FOXL2. Genet Test 2001;5:335-8. (Pubitemid 34258412)
11. Yamada T, Hayasaka S, Matsumoto M, et al. Heterozygous 17-bp deletion in the forkhead transcription factor gene, FOXL2, in a Japanese family with blepharophimosis-ptosis-epicanthus inversus syndrome. J Hum Genet 2001;46:733-6. (Pubitemid 34037336)
12. Ramirez-Castro JL, Pineda-Trujillo N, Valencia AV, et al. Mutations in FOXL2 underlying BPES (types 1 and 2) in Colombian families. Am J Med Genet 2002;113:47-51. (Pubitemid 35192586)
13. Kosaki K, Ogata T, Kosaki R, et al. A novel mutation in the FOXL2 gene in a patient with blepharophimosis syndrome: differential role of the polyalanine tract in the development of the ovary and the eyelid. Ophthalmic Genet 2002;23:43-7. (Pubitemid 34264334)
14. De Baere E, Dixon MJ, Small KW, et al. Spectrum of FOXL2 gene mutations in blepharophimosis-ptosis-epicanthus inversus (BPES) families demonstrates a genotype-phenotype correlation. Hum Mol Genet 2001;10:1591-600. (Pubitemid 32734311)
15. De Baere E, Beysen D, Oley C, et al. FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotype-phenotype correlation. Am J Hum Genet 2003;72:478-87. (Pubitemid 36194256)
16. Beysen D, Raes J, Leroy BP, et al. Deletions involving long-range conserved nongenic sequences upstream and downstream of FOXL2 as a novel disease-causing mechanism in blepharophimosis syndrome. Am J Hum Genet 2005;77(2):205-18. (Pubitemid 41022704)
17. D'haene B, Attanasio C, Beysen D, et al. Disease causing 7.4 kb cis-regulatory deletion disrupting conserved non coding sequences and their interaction with the FOXL2 promotor: Implications for mutation screening. PLoS Genet 2009;5:e1000522, Epub.
18. Harris SE, Chand AL, Winship IM, et al. Identification of novel mutations in FOXL2 associated with premature ovarian failure. Mol Hum Reprod 2002;8:729-33.
19. Laissue P, Lakhal B, Benayoun BA, et al. Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2. J Med Genet 2009;46:455-7.
20. De Baere E, Lemercier B, Christin-Maitre S, et al. FOXL2 mutation screening in a large panel of POF patients and XX males. J Med Genet 2002;39:e43.
21. Bodega B, Porta C, Crosignani PG, et al. Mutations in the coding region of the FOXL2 gene are not a major cause of idiopathic premature ovarian failure. Mol Hum Reprod 2004;10:555-7. (Pubitemid 39136813)
22. Ni F, Wen Q, Wang B, et al. Mutation analysis of FOXl2 gene in Chinese patients with premature ovarian failure. Gynecol Endocrinol 2010;26:246-9.
23. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Press, 1989:17-19.
24. Nallathambi J, Laissue P, Batista F, et al. Differential functional effects of novel mutations of the transcription factor FOXL2 in BPES patients. Hum Mutat 2008;29:E123-31.
25. Nallathambi J, Neethirajan G, Kim U, et al. FOXL2 mutations in Indian families with blepahrophimosis-ptosis-epicanthus inversus syndrome. J Genet 2007;86:165-8. (Pubitemid 350005741)
26. Kumar A, Babu M, Raghunath A, et al. Genetic analysis of a five generation Indian family with BPES: a novel missense mutation (p.Y215C). Mol Vis 2004;10:445-9. (Pubitemid 41358252)
27. Pisarska MD, Bae J, Klein C, et al. Forkhead L2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 2004;145:3424-33. (Pubitemid 38830015)
28. Beysen D, Moumne L, Veitia R, et al. Missense mutations in the forkhead domain of FOXL2 lead to subcellular mislocalization, protein aggregation and impaired transactivation. Hum Mol Genet 2008;17:2030-38. (Pubitemid 351865851)
29. Moumne L, Batista F, Benayoun BA, et al. The mutations and potential targets of the forkhead transcription factor FOXL2. Mol Cell Endocrinol 2008;282:2-11.
30. Dipietromaria A, Benayoun BA, Todeschini A-L, et al. Towards a functional classification of pathogenic FOXL2 mutations using transactivation reporter systems. Hum Mol Genet 2008;18:3324-33.
31. Gijsbers AC, D'haene B, Hilhorst-Hosfstee Y, et al. Identification of copy number variants associated with BPES like phenotypes. Hum Genet 2008;5:489-98.